Inflammation-reducing drug shows no benefit for dry age-related macular degeneration in NIH trial
Inflammation-reducing drug shows no benefit for dry age-related macular degeneration in NIH trial Retina, showing…
Inflammation-reducing drug shows no benefit for dry age-related macular degeneration in NIH trial Retina, showing…
Experimental gene therapy for giant axonal neuropathy shows promise in NIH clinical trial Treatment for…
Drug shows promise for slowing progression of rare, painful genetic disease NIH-supported clinical trial could…
Lower dose of mpox vaccine is safe and generates six-week antibody response equivalent to standard…
Faster approach for starting extended-release naltrexone to treat opioid use disorder shown effective NIH-supported clinical…
Benign nail condition linked to rare syndrome that greatly increases cancer risk NIH researchers suggest…
Acetaminophen shows promise in warding off acute respiratory distress syndrome, organ injury in patients with…
U.S. clinical trials begin for twice-yearly HIV prevention injection Studies will focus on priority populations…
NIH-sponsored trial of enterovirus D68 therapeutic begins Monoclonal antibody developed from blood of recovering patients.…
NIH-sponsored trial of nasal COVID-19 vaccine opens Candidate vaccine could provide enhanced breadth of protection…